Rebecca Rasool, Contract Specialist (CTR)

Rebecca Rasool supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in executing mission-critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research. She manages complex acquisitions for high-stakes scientific and operational capabilities, including analytical instrumentation, clinical diagnostics, and data infrastructure services. Her work directly advances CDC’s strategic priorities in infectious disease detection and laboratory capacity building, ensuring timely access to technologies and services essential for national health security. She handles a broad spectrum of procurements—from single-source scientific equipment to multi-year service contracts—often requiring specialized technical evaluation and regulatory compliance. Rasool maintains consistent working relationships with leading providers in the public health and life sciences sectors, including General Dynamics Information Technology, Cepheid, GlaxoSmithKline, New York City Health & Hospitals Corp, and MRIGLOBAL. These partnerships reflect a focus on established vendors with proven capabilities in diagnostic systems, biomedical research support, and large-scale public health operations. Her contracting approach emphasizes reliability, technical precision, and alignment with CDC’s scientific standards, often involving long-term performance-based agreements that require rigorous vendor validation and quality assurance protocols. Her procurement portfolio reflects no set-aside preferences, with all awards issued under full and open competition. This indicates a strategic emphasis on technical merit and operational readiness over socioeconomic categorizations, prioritizing the most capable and qualified vendors regardless of business size or certification status. While small business participation is not formally targeted, her contracting decisions remain compliant with all federal acquisition regulations and emphasize value-driven outcomes. Her primary procurement focus lies in NAICS 423450 for medical and hospital supplies, 334516 for analytical laboratory instruments, and 541611 for management consulting services supporting public health operations. She frequently procures next-generation diagnostic platforms, laboratory automation systems, and data analytics services critical to epidemiological modeling and outbreak response, demonstrating deep domain expertise in health technology and scientific infrastructure acquisition.